Evidence map›Paper›PMID 29302713›Full record

ArticlePsychopharmacology2018

Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.

Anna Bravermanová, Michaela Viktorinová, Filip Tylš, Tomáš Novák, Renáta Androvičová, Jakub Korčák, Jiří Horáček, Marie Balíková, Inga Griškova-Bulanova, Dominika Danielová and 5 more

Abstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Acute and post-acute neurobehavioral responses to lysergic acid diethylamide in healthy subjects: a randomized controlled study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Learning as the unifying mechanism of psychedelic action.Journal of psychopharmacology (Oxford, England) · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Psilocybin's effects on cognition and creativity: A scoping review.Journal of psychopharmacology (Oxford, England) · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Anna BravermanováNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Michaela ViktorinováNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Filip TylšNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Tomáš NovákNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Renáta AndrovičováNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Jakub KorčákNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Jiří HoráčekNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Marie BalíkováFirst Faculty of Medicine, Charles University Prague, Kateřinská 32, 121 08, Prague 2, Czech Republic.
Inga Griškova-BulanovaInstitute of Biosciences, Vilnius University, Sauletekio ave 7, 102 57, Vilnius, Lithuania.
Dominika DanielováNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Přemysl VlčekNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Pavel MohrNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Martin BrunovskýNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Vlastimil KoudelkaNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
Tomáš PáleníčekNational Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic. tomas.palenicek@nudz.cz.
Charles University · CZNational Institute of Mental Health · CZVilnius University · LT

Funding

Ministerstvo Školství, Mládeže a Tělovýchovy 260388/SVV/2017Ministerstvo Školství, Mládeže a Tělovýchovy LO1611Ministerstvo Školství, Mládeže a Tělovýchovy PROGRES Q35Ministerstvo Vnitra České Republiky VI20172020056Ministerstvo Zdravotnictví Ceské Republiky DRO - NIMH-CZ, 00023752Ministerstvo Zdravotnictví Ceské Republiky NV15-33250A
6 · The paper itself

Abstract

rationaleDisruption of auditory event-related evoked potentials (ERPs) P300 and mismatch negativity (MMN), electrophysiological markers of attentive and pre-attentive cognitive processing, is repeatedly described in psychosis and schizophrenia. Similar findings were observed in a glutamatergic model of psychosis, but the role of serotonergic 5-HT

objectivesWe studied ERPs in a serotonergic model of psychosis, induced by psilocybin, a psychedelic with 5-HT

methodsTwenty subjects (10M/10F) were given 0.26 mg/kg of psilocybin orally in a placebo-controlled, double-blind, cross-over design. ERPs (P300, MMN) were registered during the peak of intoxication. Correlations between measured electrophysiological variables and psilocin serum levels and neuropsychological effects were also analyzed.

resultsPsilocybin induced robust psychedelic effects and psychotic-like symptoms, decreased P300 amplitude (p = 0.009) but did not affect the MMN. Psilocybin's disruptive effect on P300 correlated with the intensity of the psychedelic state, which was dependent on the psilocin serum levels. We also observed a decrease in N100 amplitude (p = 0.039) in the P300 paradigm and a negative correlation between P300 and MMN amplitude (p = 0.014).

conclusionsEven though pre-attentive cognition (MMN) was not affected, processing at the early perceptual level (N100) and in higher-order cognition (P300) was significantly disrupted by psilocybin. Our results have implications for the role of 5-HT

Indexed as

Acoustic StimulationAdultAgedAttentionCognitionCross-Over StudiesDouble-Blind MethodElectroencephalographyEvent-Related Potentials, P300FemaleHallucinogensHealthy VolunteersHumansMaleMiddle AgedPsilocybinHallucinogensPsilocybinERPHumanMMNModel of psychosisP300Psilocybin

Identifiers

PMID29302713
OpenAlexW2782190599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.